Reform of pharma legislation: the debate on regulatory data protection by Giuliana Miglierini As the definition of the final contents of many new pieces of the overall revision…
The risk of a biosimilar void in Europe by Giuliana Miglierini The undergoing revision of the pharmaceutical legislation aims, among others, to redefine data protection to…
EP’s draft position on Unitary SPC and SPC Regulation revision by Giuliana Miglierini The Committee for Legal Affairs (JURI) of the European Parliament released the draft amendments to…
HERA reports on stockpiling of antimicrobials By Giuliana Miglierini The European Health Emergency Preparedness and Response Authority (HERA) has published the two final reports,…
The main contributions to the consultation on the revision of the pharmaceutical legislation by Giuliana Miglierini The European Commission has published the summary of the outcomes of the public consultation on…